Search Results - "Nicodim, Simona"

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial by Lakshmanan, Mark, Pais, Prem, Probstfield, Jeffrey, Riesmeyer, Jeffrey S, Keltai, Matyas, Cuello, Jose, Cuneo, Carlos, Cusimano, Sandra, Dominguez, Andrea, Fernandez, Alberto, Gallardo, Karina Beatriz, Lagrutta, Mariana, Romero Vidomlansky, Mariano, Sala, Jorgelina, Stival, Jorge, Virgillito, Luciana, Vogel, Daniel, Zucchiatti, Noemi, Hernandes, Mauro, Nakazone, Marcelo, Pizzato, Patricia, Reis, Heleno, Grigorova, Valentina, Aronson, Ronnie, Babin, Sandra, Bajaj, Harpreet, Berenbaum, Brian, Brault, Suzanne, Chandra, Prakash, Gauthier, Jean Sebastien, Houde, Ghislaine, Lochnan, Heather, Malik, Saleem, Mihailidis, John, Vecchiarelli, Jonathan, Aguirre, Maria Loreto, Lahsen, Rodolfo, Madrid, Claudia, Rodriguez, Jose F, Vidal Prada, Tatiana, Benesova, Radka, Kopeckova, Iva, Racicka, Eva, Szeghy Malicharova, Emilia, Zahumensky, Emil, Lier, Alexander, Schulze, Erik-Delf, Warken, Bernd, Balsay, Miklos, Birkus, Zita, Faludi, Peter, Peterfai, Eva, Reiber, István, Salamon, Csaba, Park, Sungha, Seung, Ki Bae, Mora, Lija, Avalos-Ramirez, Juan Antonio, Herrera-Marmolejo, Marisol, Parra Perez, Rosa Linda, Previn, Roopa, Villagordoa, Juan, Katzen, Colin, Rowe, David, Schmiedel, Ole, Czerwinski, Edward, Juzwiak-Czapiewska, Danuta, Nowacka, Elzbieta, Rozanska, Aleksandra, Doros, Rodica, Ferician Moza, Anca, Rosu, Mihaela, Vanghelie, Luminita, Zarnescu, Mihaela, Gelig, Ekaterina, Goryunova, Tatiana, Ilchenko, Roman, Khaykina, Elena, Shabelnikova, Olesya, Tsarkova, Olga, Swanepoel, Nicolaas, Venter, Esme, Cajas, Priscila, Garcia, Mar, Masmiquel, Luís, Ortega, Emilio, Terns, Manel, Vilaplana, Judith, Malmqvist, Lennart, Anderson, Robert, Barchini, George, Brautigam, Donald, Chakko, Simon, Charatz, Seth, Fitz-Patrick, David, Gillespie, Eve, Idriss, Soha, Lorber, Daniel, Ma, Siu-Ling, Wiegmann, Thomas

“…Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk…”
Get full text

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial by Lakshmanan, Mark, Pais, Prem, Probstfield, Jeffrey, Keltai, Matyas, Cuello, Jose, Cuneo, Carlos, Cusimano, Sandra, Dominguez, Andrea, Fernandez, Alberto, Gallardo, Karina Beatriz, Lagrutta, Mariana, Romero Vidomlansky, Mariano, Sala, Jorgelina, Stival, Jorge, Virgillito, Luciana, Vogel, Daniel, Zucchiatti, Noemi, Hernandes, Mauro, Nakazone, Marcelo, Pizzato, Patricia, Reis, Heleno, Grigorova, Valentina, Kurktschiev, Dimo, Aronson, Ronnie, Babin, Sandra, Bajaj, Harpreet, Berenbaum, Brian, Brault, Suzanne, Chandra, Prakash, Gauthier, Jean Sebastien, Houde, Ghislaine, Lochnan, Heather, Malik, Saleem, Mihailidis, John, Vecchiarelli, Jonathan, Aguirre, Maria Loreto, Lahsen, Rodolfo, Madrid, Claudia, Rodriguez, Jose F, Vidal Prada, Tatiana, Benesova, Radka, Kopeckova, Iva, Racicka, Eva, Szeghy Malicharova, Emilia, Zahumensky, Emil, Lier, Alexander, Schulze, Erik-Delf, Warken, Bernd, Balsay, Miklos, Birkus, Zita, Faludi, Peter, Peterfai, Eva, Reiber, István, Salamon, Csaba, Park, Sungha, Seung, Ki Bae, Mora, Lija, Avalos-Ramirez, Juan Antonio, Herrera-Marmolejo, Marisol, Parra Perez, Rosa Linda, Previn, Roopa, Villagordoa, Juan, Katzen, Colin, Rowe, David, Schmiedel, Ole, Czerwinski, Edward, Juzwiak-Czapiewska, Danuta, Nowacka, Elzbieta, Rozanska, Aleksandra, Doros, Rodica, Ferician Moza, Anca, Rosu, Mihaela, Vanghelie, Luminita, Zarnescu, Mihaela, Gelig, Ekaterina, Goryunova, Tatiana, Ilchenko, Roman, Khaykina, Elena, Shabelnikova, Olesya, Tsarkova, Olga, Swanepoel, Nicolaas, Venter, Esme, Cajas, Priscila, Garcia, Mar, Masmiquel, Luís, Ortega, Emilio, Terns, Manel, Vilaplana, Judith, Malmqvist, Lennart, Anderson, Robert, Barchini, George, Brautigam, Donald, Chakko, Simon, Charatz, Seth, Fitz-Patrick, David, Gillespie, Eve, Idriss, Soha, Lorber, Daniel, Ma, Siu-Ling, Wiegmann, Thomas

“…Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the…”
Get full text

Effectiveness and safety of insulin glargine Gla-300 in insulin-naïve type 2 diabetes subjects in a real-life setting-the GOAL_RO trial by Stegaru, Daniela, Nicodim, Simona, Vladu, Delia, Guțu, Olimpia, Onaca, Adriana, Pîrvu, Florina, Moise, Mihaela, Guja, Cristian

“…Basal insulin is the first choice for insulin initiation in type 2 diabetes (T2DM), with the second generation of basal insulin analogues having a lower risk…”
Get full text

Renal Vascular Lesions in Patients with Diabetes Mellitus by Nicodim, Mirela-Simona, Aşchie, Mariana, Catrinoiu, Doina, Hangan, Laurenţiu-Tony

“…Abstract Background and Aims. Patients with diabetes mellitus, especially type 2 diabetes, have often a multifactorial renal impairment. The aim of this study…”
Get full text